| |
| |
|
| Insider
Information: |
Sobecki Christopher J |
| Relationship: |
Director |
| City: |
New York |
| State: |
NY |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
277,009 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$4,399,128 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
277,009 |
|
|
| Total
Value |
$4,399,128 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
WW International |
WW |
Director |
2023-05-31 |
109,954 |
|
0 |
Premium* |
|
|
Lexicon Pharmaceuticals Inc |
LXRX |
Director |
2024-04-28 |
167,055 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
99 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 4 of 4
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| WW |
WW International |
Member, Interim Office of CEO |
– • – |
2017-03-06 |
4 |
A |
$0.00 |
$0 |
D/D |
1,840 |
93,310 |
0 |
- |
|
| WW |
WW International |
Director |
– • – |
2015-07-06 |
4 |
A |
$0.00 |
$0 |
D/D |
1,977 |
21,517 |
0 |
- |
|
| WW |
WW International |
Director |
– • – |
2023-05-31 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,053 |
109,954 |
0 |
- |
|
| WW |
WW International |
Member, Interim Office of CEO |
– • – |
2017-02-06 |
4 |
A |
$0.00 |
$0 |
D/D |
2,435 |
91,470 |
0 |
- |
|
| LXRX |
Lexicon Pharmaceuticals I... |
Director |
• • – |
2018-04-27 |
4 |
A |
$0.00 |
$0 |
D/D |
2,564 |
13,044 |
0 |
- |
|
| WW |
WW International |
Director |
– • – |
2022-07-04 |
4 |
A |
$0.00 |
$0 |
D/D |
2,745 |
66,886 |
0 |
- |
|
| WW |
WW International |
Member, Interim Office of CEO |
– • – |
2017-04-03 |
4 |
A |
$0.00 |
$0 |
D/D |
3,162 |
96,472 |
0 |
- |
|
| LXRX |
Lexicon Pharmaceuticals I... |
Director |
• • – |
2020-04-26 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,466 |
140,759 |
0 |
- |
|
| LXRX |
Lexicon Pharmaceuticals I... |
Director |
• • – |
2022-04-30 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,024 |
149,721 |
0 |
- |
|
| WW |
WW International |
Director |
– • – |
2022-10-03 |
4 |
A |
$0.00 |
$0 |
D/D |
4,595 |
71,481 |
0 |
- |
|
| WW |
WW International |
Director |
– • – |
2023-01-02 |
4 |
A |
$0.00 |
$0 |
D/D |
5,067 |
106,548 |
0 |
- |
|
| LXRX |
Lexicon Pharmaceuticals I... |
Director |
• • – |
2024-04-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
8,032 |
167,055 |
0 |
- |
|
| LXRX |
Lexicon Pharmaceuticals I... |
Director |
• • – |
2023-05-21 |
4 |
OE |
$0.00 |
$0 |
D/D |
9,302 |
159,023 |
0 |
- |
|
| LXRX |
Lexicon Pharmaceuticals I... |
Director |
• • – |
2013-05-10 |
4 |
A |
$0.00 |
$0 |
D/D |
10,101 |
22,865 |
0 |
- |
|
| LXRX |
Lexicon Pharmaceuticals I... |
Director |
• • – |
2021-04-24 |
4 |
OE |
$0.00 |
$0 |
D/D |
10,638 |
151,397 |
0 |
- |
|
| WW |
WW International |
Member, Interim Office of CEO |
– • – |
2017-01-03 |
4 |
A |
$0.00 |
$0 |
D/D |
11,162 |
89,035 |
0 |
- |
|
| LXRX |
Lexicon Pharmaceuticals I... |
Director |
• • – |
2014-04-25 |
4 |
A |
$0.00 |
$0 |
D/D |
12,820 |
35,685 |
0 |
- |
|
| LXRX |
Lexicon Pharmaceuticals I... |
Director |
• • – |
2015-04-24 |
4 |
A |
$0.00 |
$0 |
D/D |
18,691 |
54,376 |
0 |
- |
|
| WW |
WW International |
Director |
– • – |
2018-11-29 |
4 |
GD |
$0.00 |
$0 |
D/D |
20,000 |
57,080 |
0 |
- |
|
| WW |
WW International |
Director |
– • – |
2018-08-30 |
4 |
GD |
$0.00 |
$0 |
D/D |
25,000 |
76,818 |
0 |
- |
|
| LXRX |
Lexicon Pharmaceuticals I... |
Director |
• • – |
2019-09-16 |
4 |
B |
$2.38 |
$63,718 |
D/D |
25,000 |
137,293 |
2.39 |
- |
|
| WW |
WW International |
Director |
– • – |
2022-11-17 |
4 |
B |
$4.17 |
$125,124 |
D/D |
30,000 |
101,481 |
2.39 |
- |
|
| WW |
WW International |
Director |
– • – |
2016-03-01 |
4 |
B |
$12.20 |
$609,815 |
D/D |
50,000 |
74,493 |
2.39 |
- |
|
| LXRX |
Lexicon Pharmaceuticals I... |
Director |
• • – |
2019-09-13 |
4 |
B |
$2.25 |
$238,750 |
D/D |
99,249 |
112,293 |
2.39 |
- |
|
99 Records found
|
|
Page 4 of 4 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
